Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98


Cancer burden among HIV-positive persons in Nigeria: preliminary findings from the Nigerian AIDS-cancer match study.

Akarolo-Anthony SN, Maso LD, Igbinoba F, Mbulaiteye SM, Adebamowo CA.

Infect Agent Cancer. 2014 Mar 5;9(1):1. doi: 10.1186/1750-9378-9-1.


HIV and cancer registry linkage identifies a substantial burden of cancers in persons with HIV in India.

Godbole SV, Nandy K, Gauniyal M, Nalawade P, Sane S, Koyande S, Toyama J, Hegde A, Virgo P, Bhatia K, Paranjape RS, Risbud AR, Mbulaiteye SM, Mitsuyasu RT.

Medicine (Baltimore). 2016 Sep;95(37):e4850. doi: 10.1097/MD.0000000000004850.


Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.

Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, Rapiti E, Levi F, Jundt G, Fisch T, Bordoni A, De Weck D, Franceschi S; Swiss HIV Cohort.

J Natl Cancer Inst. 2005 Mar 16;97(6):425-32.


Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study.

Mbulaiteye SM, Katabira ET, Wabinga H, Parkin DM, Virgo P, Ochai R, Workneh M, Coutinho A, Engels EA.

Int J Cancer. 2006 Feb 15;118(4):985-90.


Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study.

Hernández-Ramírez RU, Shiels MS, Dubrow R, Engels EA.

Lancet HIV. 2017 Nov;4(11):e495-e504. doi: 10.1016/S2352-3018(17)30125-X. Epub 2017 Aug 10.


Risk of cancer among women with AIDS in New York City.

Fordyce EJ, Wang Z, Kahn AR, Gallagher BK, Merlos I, Ly S, Schymura M, Chiasson MA.

AIDS Public Policy J. 2000 Fall-Winter;15(3-4):95-104.


HIV-related malignancies: community-based study using linkage of cancer registry and HIV registry data.

Cooksley CD, Hwang LY, Waller DK, Ford CE.

Int J STD AIDS. 1999 Dec;10(12):795-802.


Cancer incidence among HIV-positive women in British Columbia, Canada: Heightened risk of virus-related malignancies.

Salters KA, Cescon A, Zhang W, Ogilvie G, Murray MC, Coldman A, Hamm J, Chiu CG, Montaner JS, Wiseman SM, Money D, Pick N, Hogg RS.

HIV Med. 2016 Mar;17(3):188-95. doi: 10.1111/hiv.12290. Epub 2015 Aug 12.


Cancer risk in people infected with human immunodeficiency virus in the United States.

Engels EA, Biggar RJ, Hall HI, Cross H, Crutchfield A, Finch JL, Grigg R, Hylton T, Pawlish KS, McNeel TS, Goedert JJ.

Int J Cancer. 2008 Jul 1;123(1):187-94. doi: 10.1002/ijc.23487.


Cancer incidence in AIDS patients in Catalonia, Spain.

Galceran J, Marcos-Gragera R, Soler M, Romaguera A, Ameijide A, Izquierdo A, Borràs J, de Sanjosé S, Casabona J.

Eur J Cancer. 2007 Apr;43(6):1085-91. Epub 2007 Mar 8.


Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007.

Shiels MS, Pfeiffer RM, Hall HI, Li J, Goedert JJ, Morton LM, Hartge P, Engels EA.

JAMA. 2011 Apr 13;305(14):1450-9. doi: 10.1001/jama.2011.396. Erratum in: JAMA. 2011 Oct 12;306(14):1548.


Underestimation of relative risks by standardized incidence ratios for AIDS-related cancers.

Chaturvedi AK, Mbulaiteye SM, Engels EA.

Ann Epidemiol. 2008 Mar;18(3):230-4.


Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy. Cancer and AIDS Registry Linkage Study.

Franceschi S, Dal Maso L, Arniani S, Crosignani P, Vercelli M, Simonato L, Falcini F, Zanetti R, Barchielli A, Serraino D, Rezza G.

Br J Cancer. 1998 Oct;78(7):966-70.


Cancer incidence in a cohort of human immunodeficiency virus seroconverters. HIV Italian Seroconversion Study Group.

Serraino D, Pezzotti P, Dorrucci M, Alliegro MB, Sinicco A, Rezza G.

Cancer. 1997 Mar 1;79(5):1004-8.


Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.

International Collaboration on HIV and Cancer.

J Natl Cancer Inst. 2000 Nov 15;92(22):1823-30.


Burden of non-AIDS-defining and non-virus-related cancers among HIV-infected patients in the combined antiretroviral therapy era.

Albini L, Calabresi A, Gotti D, Ferraresi A, Festa A, Donato F, Magoni M, Castelli F, Quiros-Roldan E.

AIDS Res Hum Retroviruses. 2013 Aug;29(8):1097-104. doi: 10.1089/AID.2012.0321. Epub 2013 May 9.


Cancer incidence in Nigeria: a report from population-based cancer registries.

Jedy-Agba E, Curado MP, Ogunbiyi O, Oga E, Fabowale T, Igbinoba F, Osubor G, Otu T, Kumai H, Koechlin A, Osinubi P, Dakum P, Blattner W, Adebamowo CA.

Cancer Epidemiol. 2012 Oct;36(5):e271-8. doi: 10.1016/j.canep.2012.04.007. Epub 2012 May 22.


Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of Northern Italy, 1999-2009.

Calabresi A, Ferraresi A, Festa A, Scarcella C, Donato F, Vassallo F, Limina R, Castelli F, Quiros-Roldan E; Brescia HIV Cancer Study Group.

HIV Med. 2013 Sep;14(8):481-90. doi: 10.1111/hiv.12034. Epub 2013 Apr 7.


Risk of cancer in persons with AIDS in Italy, 1985-1998.

Dal Maso L, Franceschi S, Polesel J, Braga C, Piselli P, Crocetti E, Falcini F, Guzzinati S, Zanetti R, Vercelli M, Rezza G; Cancer and AIDS Registy Linkage Study.

Br J Cancer. 2003 Jul 7;89(1):94-100.


AIDS-related cancer and severity of immunosuppression in persons with AIDS.

Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA; HIV/AIDS Cancer Match Study.

J Natl Cancer Inst. 2007 Jun 20;99(12):962-72. Epub 2007 Jun 12.


Supplemental Content

Support Center